Injection device maker Milestone Scientific (NYSE:MLSS) topped expectations on Wall Street today with its second quarter results.
The Livingston, N.J.-based company posted a net loss of -$1.5 million on sales of $2.5 million for the 3 months ended June 30, for bottom-line growth of 6.8% on sales growth of 4.2% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Milestone Scientific logs Q2 beat appeared first on MassDevice.